ID: ALA3403523

Max Phase: Preclinical

Molecular Formula: C14H12N4O4

Molecular Weight: 300.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)Nc1ccc(C(=O)Oc2cccc([N+](=O)[O-])c2)cc1

Standard InChI:  InChI=1S/C14H12N4O4/c15-14(16)17-10-6-4-9(5-7-10)13(19)22-12-3-1-2-11(8-12)18(20)21/h1-8H,(H4,15,16,17)

Standard InChI Key:  LIJHCOQWUYPXSK-UHFFFAOYSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.27Molecular Weight (Monoisotopic): 300.0859AlogP: 2.12#Rotatable Bonds: 4
Polar Surface Area: 131.34Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.09CX LogP: 2.55CX LogD: 1.78
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.20Np Likeness Score: -1.16

References

1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW..  (2015)  Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.,  23  (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072]

Source